Recent advances in coronary angioscopy
29
which might act as a cushion. Therefore, it is conceivable
that to control neointimal regeneration over 100 m and
below appropriate thickness which does not cause significant
restenosis is necessary to prevent LST.
[20] Okada K, Ueda Y, Oyabu J, Ogasawara N, Hirayama A, Kodama
K. Plaque color analysis by the conventional yellow-color grad-
ing system and quantitative measurement using LCH color
space. J Interv Cardiol 2007;20:324—34.
[
21] Uchida Y, Egami H. What determines depth of yellow color
of coronary plaques. Proceedings of 20th annual meeting of
Japanese Association of Cardioangioscopy 2005:15.
References
[
22] Ohtani T, Ueda Y, Mizoe I, Oyabu J, Okada K, Hirayama A,
Kodama K. Number of yellow plaques detected in a coronary
artery is associated with future risk of acute coronary syn-
drome: detection of vulnerable patients by angioscopy. J Am
Coll Cardiol 2006;47:2194—200.
[
[
1] Allen DS, Graham EA. Intracardiac surgery: a new method. Am
Med Assoc 1922;79:1028.
2] Uchida Y, Tomaru T, Sumino S, Kato S, Sugimoto T. Fiberoptic
observation of thrombosis and thrombolysis in isolated human
coronary artery. Am Heart J 1986;112:694—6.
[23] Takano M, Jang IK, Inami S, Yamamoto M, Murakami D, Komatsu
K, Seimiya K, Ohba T, Mizuno K. In vivo comparison of optical
coherence tomography and angioscopy for the evaluation of
coronary plaque characteristics. Am J Cardiol 2008;101:471—6.
[24] Komatsu S, Ueda Y, Omori Y, Kodama K. Diagnosis of vulner-
able plaque and vulnerable patients by coronary angioscopy
and multi-detector row computed tomography (MCDCT)-from
invasive to non-invasive plaque imaging. Vasc Dis Preven
2006;3:319—25.
[25] Uchida Y, Egami H, Kameda N. Pitfalls of angioscopy in detect-
ing vulnerable coronary plaques. Circ J 2010;74:273.
[26] Uchida Y. Angioscopic detection of vulnerable coronary
plaques. Curr Cardiovasc Imag Rep 2010;3:222—9.
[27] Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull
Jr W, Rosenfeld ME, Schwarz CJ, Wagner WD, Wissler RW. A
definition of advanced types of atherosclerotic lesions and a
histological classification of atherosclerosis: a report from the
committee on vascular lesions of the council on arterioscle-
rosis, American Heart Association. Circulation 1995;92:1355—
74.
[28] Tavora F, Cresswell N, Li L, Ripple M, Fowler D, Burke A.
Sudden coronary death caused by pathologic intimal thicken-
ing without atheromatous plaque formation. Cardiovasc Pathol
2009;26:55—61.
[
[
3] Spears JR, Spokojny AM, Marais HJ. Coronary angioscopy during
cardiac catheterization. J Am Coll Cardiol 1985;6:93—7.
4] Litvack F, Grundfest WS, Lee ME. Angioscopic visualization
of blood vessel interior in animals and humans. Clin Cardiol
1985;8:65—70.
[
[
[
[
5] Uchida Y, Nakamura F, Tomaru T, Furuse A, Fujimori Y,
Hasegawa K. Percutaneous coronary angioscopy in patients
with ischemic heart disease. Am Heart J 1987;114:1216—22.
6] Hoeler M, Homback V, Hoepp HW. Percutaneous coronary
angioscopy during cardiac catheterization. J Am Coll Cardiol
1988;11(65A) [abstract].
7] Uchida Y, Tomaru T, Sugimoto T. Angioscopic observation of
coronary luminal changes induced by PTCA. Proc Jpn Coll Angiol
1984;85 [abstract].
8] Uchida Y, Hasegawa K, Kawamura K, Shibuya I. Angioscopic
observation of the coronary luminal changes induced by per-
cutaneous transluminal coronary angioplasty. Am Heart J
1989;117:769—76.
[
9] Nakamura F, Kvasnicka J, Uchida Y, Geschwind HJ. Percuta-
neous angioscopic evaluation of luminal changes induced by
excimer laser angioplasty. Am Heart J 1992;124:1467—72.
[
[
[
10] Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage
of stents in human coronary arteries observed by angioscopy. J
Am Coll Cardiol 1994;23:341—6.
11] Ishikawa H, Uchida Y. Angioscopic features of coronary artery in
Kawasaki disease. In: Proceedings of 4th international Kawasaki
disease conference. 1991. p. 20—2.
12] Sherman CT, Litvak F, Grandest W, Lee M, Hickey A, Chaux
R, Blanche C, Matloff J, Morgenstern L. Coronary angioscopy
in patients with unstable angina pectoris. New Engl J Med
[29] Uchida Y, Uchida Y, Sakurai T, Kanai M, Shirai S, Oshima T,
Tabata T. Fluffy luminal surface of the non-stenotic culprit
coronary artery in patients with acute coronary syndrome. Circ
J 2010;74:2379—85.
[30] Romeo F, Li D, Shi M, Mehta JL. Carvedilol prevents
epinephrine-induced apoptosis in human coronary artery
endothelial cell: modulation of Fas/Fas ligand and caspase-3
pathway. Cardiovasc Res 2000;45:788—94.
1986;315:913—9.
[
[
[
13] Uchida Y, Fujimori Y, Ohsawa H, Noike H. Angioscopic eval-
uation of the stabilizing effects of bezafibrate on coronary
plaques. Coronary 1997;16:293—301.
14] Uchida Y, Tomaru T, Sugimoto T. Angioscopic observation of
coronary luminal changes induced by PTCA. Proc Jpn Coll Angiol
[31] Weinmann P, Jouan M, Nguyen QD, Lacroix B, Groiselle C, Bonte
JP, Luc G. Quantitative analysis of cholesterol and cholesteryl
esters in human atherosclerotic plaques using near-infrared
Raman spectroscopy. Atherosclerosis 1998;140:81—8.
[32] Garg R, Waxman S. Catheter-based near-infrared spectroscopy
for imaging of lipid-rich plaques. Curr Cardiovasc Imaging Rep
2010;3:403—11.
[33] Uchida Y, Noike H, Tomaru T, Kanai M, Sakurai T. Two-
dimensional imaging of lipids deposited in the coronary
plaques by near-infrared fluorescence angioscopy. Circulation
2007;118(Suppl. II):617.
1984;50 [abstract].
15] Uchida Y, Nakamura F, Tomaru T, Oshima T, Sasaki T, Morizuki
S, Hirose J. Prediction of acute coronary syndromes by per-
cutaneous coronary angioscopy in patients with stable angina
pectoris. Am Heart J 1995;130:195—203.
[
[
16] Uchida Y. Coronary angioscopy. Futura: Armonk, NY; 2001. p.
79—100.
[34] Uchida Y, Uchida Y, Kawai S, Kanamaru R, Sugiyama Y, Tomaru
T, Maezawa Y, Kameda N. Detection of vulnerable coronary
plaques by color fluorescent angioscopy. JACC Cardiovasc Imag-
ing 2010;3:398—408.
17] Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assess-
ment of plaque vulnerability by angioscopic classification of
plaque color. Am Heart J 2004;148:333—5.
[
[
18] Uchida Y, Fujimori Y, Ohsawa H, et al. Angioscopic evalua-
tion of stabilizing effects of bezafibrate on coronary plaques
in patients with coronary artery disease. Diag Therap Endosc
[35] Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestd L, Oie
E, Aukrust P. Atherosclerotic plaque stability—–what determines
the fate of plaque? Prog Cardiovasc Dis 2008;51:183—94.
[36] Shah PK. Inflammation and plaque vulnerability. Cardiovasc
Drugs Ther 2009;23:31—40.
[37] Aiyar N, Disa J, Ao Z, Ju H, Nerurkar S, Willette RN, Macphee
CH, Johns DG, Dougla SA. Lysophosphatidylcholine induces
inflammatory activation of human coronary artery smooth mus-
cle cells. Mol Cell Biochem 2007;295:113—20.
2000;7:21—8.
19] Ishibashi F, Mizuno K, Kawamura A, Shin PP, Nesto RW, Waxman
S. High yellow color intensity by angioscopy with quantita-
tive colorimetry to identify high-risk features in culprit lesions
of patients with acute coronary syndromes. Am J Cardiol
2007;100:1207—11.